Goldman lifts Edwards Lifesciences Corp [EW] price estimate. Who else is bullish?

Edwards Lifesciences Corp [NYSE: EW] closed the trading session at $88.84.

The stocks have a year to date performance of 16.51 percent and weekly performance of 1.22 percent. The stock has been moved at 18.64 percent over the last six months. The stock has performed -1.05 percent around the most recent 30 days and changed -4.51 percent over the most recent 3-months.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

If compared to the average trading volume of 2.72M shares, EW reached to a volume of 5442853 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here’s what leading stock market gurus have to say about Edwards Lifesciences Corp [EW]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for EW shares is $96.69 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on EW stock is a recommendation set at 1.97. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Goldman have made an estimate for Edwards Lifesciences Corp shares, keeping their opinion on the stock as Buy, with their previous recommendation back on May 30, 2024. While these analysts kept the previous recommendation, Citigroup dropped their target price from $98 to $105. The new note on the price target was released on May 22, 2024, representing the official price target for Edwards Lifesciences Corp stock.

The Average True Range (ATR) for Edwards Lifesciences Corp is set at 1.97, with the Price to Sales ratio for EW stock in the period of the last 12 months amounting to 8.71. The Price to Book ratio for the last quarter was 7.52, with the Price to Cash per share for the same quarter was set at 2.82. Price to Free Cash Flow for EW in the course of the last twelve months was 197.25 with Quick ratio for the last quarter at 2.67.

EW stock trade performance evaluation

Edwards Lifesciences Corp [EW] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 1.22. With this latest performance, EW shares dropped by -1.05% in over the last four-week period, additionally plugging by 18.64% over the last 6 months – not to mention a drop of -3.34% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for EW stock in for the last two-week period is set at 55.18, with the RSI for the last a single of trading hit 59.22, and the three-weeks RSI is set at 53.20 for Edwards Lifesciences Corp [EW]. The present Moving Average for the last 50 days of trading for this stock 87.57, while it was recorded at 87.84 for the last single week of trading, and 79.58 for the last 200 days.

Edwards Lifesciences Corp [EW]: An insightful look at the core fundamentals

Edwards Lifesciences Corp’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.67 and a Current Ratio set at 3.75.

Earnings per share (EPS) analysis for Edwards Lifesciences Corp [EW] stock

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for EW. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Edwards Lifesciences Corp go to 10.72%.

Edwards Lifesciences Corp [EW]: Institutional Ownership

The top three institutional holders of EW stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.4983%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $200.69 billion in EW stocks shares; and BERKSHIRE HATHAWAY INC, currently with $174.35 billion in EW stock with ownership which is approximately 5.8386%.